Navigation Links
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Date:5/7/2009

ly following infusion of study drug (i.e., during the first hour of treatment) in patients receiving ANX-514 relative to those receiving Taxotere, but, at 10 minutes after the completion of infusion, docetaxel blood-levels were comparable and remained so through the end of the observation period. The Company is analyzing these short-term increased levels, which were the reason ANX-514 was outside the bounds established by the FDA for determining bioequivalence. Analyzing blood-levels at all time points beginning 10 minutes after the completion of drug administration, pharmaceutical equivalence of ANX-514 and Taxotere was observed.

The bioequivalence study of ANX-514 was an open-label, two-period, randomized, crossover comparison of ANX-514 and Taxotere in patients with advanced cancer potentially sensitive to docetaxel. The primary objective was demonstrating the pharmacokinetic equivalence of ANX-514 and Taxotere and determining the safety of a single dose of ANX-514 was a secondary objective. On Day 1, patients were dosed with either ANX-514 or Taxotere and, on Day 22, were dosed with the other drug. Patients were premedicated with corticosteroids prior to treatment on Day 1 and on Day 22. The FDA has indicated that this single bioequivalence study, should it demonstrate pharmacokinetic equivalence between ANX-514 and Taxotere, would provide sufficient data to support an NDA.

Pharmacokinetic equivalence was assessed by a statistical comparison of both the areas under the curve (AUC) and maximum plasma concentrations (Cmax) and determined based on federal regulations and FDA guidance regarding bioequivalence studies. If the upper and lower bounds of the AUC ratio's and the Cmax ratio's 90% confidence interval ranged from 0.80 to 1.25, ANX-514 and Taxotere would be considered to have equivalent pharmacokinetics. Pursuant to the study's protocol and statistical analysis plan, data from 31 patients who received both
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
2. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
3. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
4. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
5. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
9. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
10. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... find the best plan at the right price ... the end of the year, thousands of Nebraska Medicare ... coverage. This is when the state,s 268,000 Medicare ... sign up and pay for in 2010. ,, ... decision, says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...
(Date:12/15/2009)... SALT LAKE CITY, Dec. 15 ... it has signed a preferred vendor agreement to ... Therapy Providers, Inc. (PTP), a nationwide network of ... thrilled to be working with Preferred Therapy Providers," ... sales and marketing at Dynatronics. "Their vast network ...
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... Boehringer Ingelheim GmbH: PharmaVitae Profile ... ,, This analysis examines the historical ... the Rx pharmaceutical sector. The profile encompasses ... assessment of financial performance, with 1-6 year ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc. 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7XL Insurance Strengthens Equine Underwriting Team 61601 1XL Insurance Strengthens Equine Underwriting Team 61601 2Evolution Evidence Overturned 61598 1Evolution Evidence Overturned 61598 2Evolution Evidence Overturned 61598 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 1Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 2Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 3Mainstay of the Global Workforce 40 65 Year Olds Hit Hardest by Chronic Obstructive Pulmonary Disease 28COPD 29 14894 4
... FREMONT, Calif., Oct. 29 Vermillion, Inc.,(OTC Bulletin ... with Quest,Diagnostics to extend the Strategic Alliance Agreement ... enable the companies to continue,work on the development ... The OVA1 test is intended to identify women ...
... Study showed no consistent differences in bone mineral ... Advair Diskus 250/50 (fluticasone,propionate and salmeterol inhalation powder) ... long term use of Advair(R) in patients,with COPD, ... today that data from a three-year study of ...
Other Medicine Technology:Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 2Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 3Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc. 4Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 2Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD 3
(Date:12/15/2009)... lll. Physical activity is known to reduce depression ... new study indicates that this effect stems from an ... his or her ability to achieve certain physical ... Psychosomatic Medicine . , "We base our arguments on ... a professor of kinesiology and community health at the ...
(Date:12/15/2009)... as tutoring children, can help older adults delay ... study led by researchers at the Johns Hopkins ... resonance imaging (fMRI), the researchers found that seniors ... in key brain regions that support cognitive abilities ... The study is the first of its kind ...
(Date:12/15/2009)... will call for help, experts say , , TUESDAY, Dec. ... by teaching children how to spot the signs of ... new study shows. , Emergency medical treatment within three ... extent of brain damage and lead to better recovery. ... included 515 sixth graders in Texas who were divided ...
(Date:12/15/2009)... that phthalates actually cause the condition, experts ... Common chemicals found in plastic toys and elsewhere ... in boys, preliminary research suggests. , The ... pediatricians, adds fuel to the debate over these ... by some scientists. The chemical industry claims the ...
(Date:12/15/2009)... BlockMaster a leading provider of secure USB devices, today launches ... USB flash drive. The software is designed to provide better ... series of new features and range of licensing options. ... ... 2009 -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of ...
Breaking Medicine News(10 mins):Health News:Mastery of physical goals lessens disease-related depression and fatigue 2Health News:For older adults, participating in social service activities can improve brain functions 2Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3
... of green tea has long been touted for its ... have found// that a component of green tea, combined ... the spread of human prostate cancer. ,In ... from University of Wisconsin-Madison demonstrate that low doses of ...
... a common complication that affects up to 25 percent ... significant risk factor for later deadly bronchiolotis obliterans syndrome ... first issue for March 2007 of the American Journal ... American Thoracic Society. ,Ramsey R. Hachem, M.D., ...
... bestseller ‘French Women Don’t Get Fat’ may need a title ... million// people are obese and 20 million are overweight. ... heads for effective ways to come back to the former ... Something they are doing now is coming down hard on ...
... marketing firm owner, is in the news again. His company will ... had to be culled last month, in the wake of a ... , The company, which has a 4800 strong workforce, had reported ... expected to pay the compensation, though there are talks that the ...
... hearing loss are five times more likely to contract ... March 2007 edition of Otolaryngology-Head and Neck Surgery. ... period, monitored 663,963 children born in Denmark between 1995 ... loss and meningitis; of these children, five were first ...
... 2007-08 for health and education has been increased, there ... deputy director (Asia), UN Millennium Campaign. ,"The ... to education and three percent to health," Pimple told ... said, though marks an increase from the previous budgets, ...
Other Medicine News:Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 2Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 3Health News:Primary Graft Dysfunction Is Risk Factor For Lung Transplant Problem 2Health News:Turkey Giant to Receive King-sized Compensation 2Health News:Hearing Loss in Children Leads to Substantial Meningitis Risk 2Health News:Allocation for Health, Education Not Enough: UN Official 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: